CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Other events
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event New debt or obligation · Other events
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · New debt or obligation
- 424B3 Offering Prospectus
- SC 13D/A Stake Beneficial Ownership Report
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 12 of 27 · 521 filings